From: Determinants of quality of life among Malaysian cancer patients: a cross-sectional study
Characteristics | Gender | Statistics | Eta square | |
---|---|---|---|---|
Male No. % | Female No. % | |||
Type of Cancer | ||||
 Breast | 0(0.00%) | 523(56.8%) | 1206.17 P < 0.001* | 0.86 |
 Ovarian | 0(0.00%) | 62(6.7%) | ||
 Cervical | 0(0.00%) | 143(15.5%) | ||
 Colorectal | 436(62.5%) | 14(1.5%) | ||
 Lymphoma | 81(11.6%) | 21(2.3%) | ||
 Stomach | 52(7.4%) | 109(11.8%) | ||
 Others | 129(18.5%) | 50(5.4%) | ||
Treatment side effect | ||||
 No side effect | 73(10.5%) | 34(3.7%) | Chi-square = 31.23 P < 0.001* | 0.14 |
 One side effect | 30(4.3%) | 32(3.5%) | ||
 Two side effect | 76(10.9%) | 100(10.8%) | ||
 ≥ Three side effec | 519(74.4%) | 756(82.0%) |